Bioactive saponins and glycosides. II. Senegae radix. (2): Chemical structures, hypoglycemic activity, and ethanol absorption-inhibitory effect of E-senegasaponin c, Z-senegasaponin c, and Z-senegins II, III, and IV

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 7, 1996, Pages 1305-1313

  Yoshikawa, Masayuki ^a   Murakami, Toshiyuki ^a   Matsuda, Hisashi ^a   Ueno, Takahiro ^a   Kadoya, Masashi ^a   Yamahara, Johji ^a   Murakami, Nobutoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

alcohol absorption inhibitor; E senegasaponin c; hypoglycemic activity; Polygala senega var. latifolia; Senegae Radix; Z senegin

Indexed keywords

ALCOHOL; ANTIDIABETIC AGENT; GLUCOSE; GLYCOSIDE; SAPONIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; HYPOGLYCEMIA; MALE; MEDICINAL PLANT; NONHUMAN; ORAL DRUG ADMINISTRATION; PLANT ROOT; RAT;

EID: 0030058472     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.1305     Document Type: Article

References (18)

1. Part I: Yoshikawa M., Murakami T., Ueno T., Kadoya M., Matsuda H., Yamahara J., Murakami N., Chem. Pharm. Bull., 43, 2115-2122 (1995).
2. a) Yoshikawa M., Ueda T., Muraoka O., Aoyama H., Matsuda H., Shimoda H., Yamahara J., Murakami N., Chem. Pharm. Bull., 43, 532-534 (1995)
3. b) Yamahara J., Matsuda H., Shimoda H., Wariishi N., Yagi N., Murakami N., Yoshikawa M., Nippon Yakurigaku Zasshi, 105, 365-379 (1995)
4. c) Yoshikawa M., Shimada H., Shimoda H., Matsuda H., Yamahara J., Murakami N., Chem. Pharm. Bull., 43, 1245-1247 (1995)
5. d) Yamahara J., Matsuda H., Yamaguchi S., Shimoda H., Murakami N., Yoshikawa M., Natural Medicines, 43, 70-83 (1995)
6. e) Yamahara J., Miki A., Tsukamoto K., Murakami N., Yoshikawa M., ibid., 43, 84-87 (1995)
7. f) Yoshikawa M., Yamaguchi S., Nishisaka H., Yamahara J., Murakami N., Chem. Pharm. Bull., 43, 1462-1465 (1995).
8. Yoshikawa M., Murakami T., Ueno T., Kadoya M., Matsuda H., Yamahara J., Murakami N., Chem. Pharm. Bull., 43, 350-352 (1995).
9. a) Yoshikawa M., Harada E., Matsuda H., Murakami T., Yamahara J., Murakami N., Chem. Pharm. Bull., 41, 2069-2071 (1993)
10. b) Yoshikawa M., Harada E., Murakami T., Matsuda H., Yamahara J., Murakami N., ibid., 42, 742-744 (1994)
11. c) Yoshikawa M., Matsuda H., Harada E., Murakami T., Wariishi N., Yamahara J., Murakami N., ibid., 42, 1354-1356 (1994)
12. d) Yoshikawa M., Harada E., Murakami T., Matsuda H., Wariishi N., Yamahara J., Murakami N., Kitagawa I., ibid., 42, 1357-1359 (1994)
13. e) Yoshikawa M., Murakami T., Kadoya M., Matsuda H., Yamahara J., Muraoka O., Murakami N., Heterocycles, 43, 1621-1626 (1995)
14. f) Yoshikawa M., Yoshizumi S., Ueno T., Matsuda H., Murakami T., Yamahara J., Murakami N., Chem. Pharm. Bull., 43, 1878-1882 (1995).
15. Yamahara J., Murakami N., Matsuda H., Murakami T., Ueno T., Yoshikawa M., presented at the 42nd Annual Meeting of the Japanese Society of Pharmacognosy, Fukuyama, September 1995, Abstract Paper p. 125.
16. a) Tsukitani Y., Kawanishi S., Shoji J., Chem. Pharm. Bull., 21, 791-799 (1973)
17. b) Tsukitani Y., Shoji J., ibid., 21, 1564-1574 (1973).
18. 13C COSY), distortionless enhancement by polarization transfer (DEPT) and HMBC experiments.